Overview
- 95 inspections across 85 sites are on record.
- 208 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-21.
At a glance
Inspections
95
Sites
85
Observations
208
Career since
Oct 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Solaris Pharma Corporation | 21 Apr 2026 | Human Drugs | On file |
| HEC Pharm Co., Ltd. | 21 Nov 2025 | Human Drugs | On file |
| Hubei Biocause Heilen Pharmaceutical Co., Ltd. | 14 Nov 2025 | Human Drugs | On file |
| Hubei Gedian Humanwell Pharmaceutical Co., Ltd. | 7 Nov 2025 | Human Drugs | On file |
| Quality Packaging Specialists International, LLC | 3 Oct 2025 | Human Drugs | On file |
Sites inspected
Solaris Pharma CorporationSomerset, United States1 insp.
HEC Pharm Co., Ltd.Yidu, China1 insp.
Hubei Biocause Heilen Pharmaceutical Co., Ltd.Jingmen, China1 insp.
Hubei Gedian Humanwell Pharmaceutical Co., Ltd.Ezhou, China1 insp.
Quality Packaging Specialists International, LLCBurlington, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Nicholas A Violand9 shared
Nancy M Espinal5 shared
James R Birkenstamm4 shared
Karishma G Gopaul2 shared
Maria Estrella2 shared
Ankur C Patel2 shared
Frederick Razzaghi2 shared
Claude Noel Y Zanetsie1 shared
Catherine O Lamptey1 shared
Jonathan Ho1 shared
Full investigator report
Get the verbatim findings behind Adetutu M Gidado's 208 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site